Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
PMV Pharmaceuticals, Inc. (PMVP) had Income from Continuous Operations of $-77.74M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-77.74M |
|
-- |
|
-- |
|
$86.21M |
|
$-86.21M |
|
$6.29M |
|
$-79.91M |
|
$-79.91M |
|
$-77.74M |
|
|
Income from Continuous Operations |
$-77.74M |
$-77.74M |
|
$-77.74M |
|
$-86.21M |
|
$-88.84M |
|
52.54M |
|
52.54M |
|
$-1.48 |
|
$-1.48 |
|
| Balance Sheet Financials | |
$115.23M |
|
$0.24M |
|
$1.33M |
|
$116.56M |
|
$11.41M |
|
-- |
|
$0.43M |
|
$11.85M |
|
$104.71M |
|
$104.71M |
|
$104.71M |
|
53.33M |
|
| Cash Flow Statement Financials | |
$-73.58M |
|
$70.17M |
|
$0.51M |
|
$40.88M |
|
$37.98M |
|
$-2.89M |
|
$5.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-73.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-74.24% |
|
-74.24% |
|
-66.70% |
|
-74.24% |
|
$1.96 |
|
$-1.40 |
|
$-1.40 |
|